Investigating obesity or overweight condition correlated to many co-morbidities research hub

A Phase IIb Randomised, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety and Tolerability of Co-administration of AZD9550 and AZD6234 in Participants Living With Obesity or Overweight with Comorbidity

This study is looking at a new combination of medicines (AZD9550 and AZD6234) for people who are overweight or have obesity and other health problems. Researchers want to see if these medicines help with weight loss and if they are safe to use.